About EpiRet
EpiRet GmbH develops, produces and markets visual prostheses that can restore the vision of blind patients with certain forms of blindness (retinitis pigmentosa and age-related macular degeneration) to a limited extent. The development of these implants was funded by the German Federal Ministry of Education and Research for almost 12 years.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Facts about EpiRet
Facts about EpiRet
- Focus : Manufacturer
- Industry : Biotechnology
Here you will find EpiRet GmbH
Last viewed contents
Computer simulation of protein malfunction related to Alzheimer's disease
Takeda reigns supreme among Japanese pharma companies - Modest growth rates of 2007 sales by on average 3.2% YoY reflects challenges imposed by the health care system and an aging product portfolio
ESF's workshop restores good name of sugar - Glycoscience now hotbed of medical research
Anatomical_terms_of_location
